Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study - PubMed (original) (raw)
Clinical Trial
. 1992 Feb 15;116(4):273-8.
doi: 10.7326/0003-4819-116-4-273.
Affiliations
- PMID: 1733381
- DOI: 10.7326/0003-4819-116-4-273
Clinical Trial
Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study
P Saikku et al. Ann Intern Med. 1992.
Abstract
Objective: To investigate in the prospective Helsinki Heart Study, whether chronic Chlamydia pneumoniae infection, indicated by elevated antibody titers against the pathogen, chlamydial lipopolysaccharide-containing immune complexes, or both, is a risk factor for coronary heart disease.
Design and setting: The Helsinki Heart Study was a randomized, double-blind, 5-year clinical trial to test the efficacy of gemfibrozil in reducing the risk for coronary heart disease. Participants were randomized to receive either gemfibrozil (2046 patients) or placebo (2035 patients). Fatal and nonfatal myocardial infarction and sudden cardiac death were the main study end points. Serum samples were collected at 3-month intervals from all patients.
Patients: One hundred forty cardiac events occurred during the follow-up period. Serum samples from 103 case patients obtained 3 to 6 months before a cardiac end point were matched with those from controls for time point, locality, and treatment. Samples were tested for markers of chronic chlamydial infection.
Measurements: Immunoglobulin A (IgA) and G (IgG) antibodies to C. pneumoniae were measured using the microimmunofluorescence method. Lipopolysaccharide-containing immune complexes were measured using two antigen-specific enzyme immunoassays, the lipopolysaccharide-capture and immunoglobulin M (IgM)-capture methods.
Main results: Using a conditional logistic regression model, odds ratios for the development of coronary heart disease were 2.7 (95% CI, 1.1 to 6.5) for elevated IgA titers, 2.1 (CI, 1.1 to 3.9) for the presence of immune complexes, and 2.9 (CI, 1.5 to 5.4) for the presence of both factors. If we adjusted for other coronary heart disease risk factors such as age, hypertension, and smoking, the corresponding values would be 2.3 (CI, 0.9 to 6.2), 1.8 (CI, 0.9 to 3.6), and 2.6 (CI, 1.3 to 5.2), respectively.
Conclusion: The results suggest that chronic C. pneumoniae infection may be a significant risk factor for the development of coronary heart disease.
Comment in
- Chlamydia, smoking, and heart disease.
Hahn DL. Hahn DL. Ann Intern Med. 1992 Jul 15;117(2):171. doi: 10.7326/0003-4819-117-2-171_1. Ann Intern Med. 1992. PMID: 1605436 No abstract available.
Similar articles
- Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes.
Wong BY, Gnarpe J, Teo KK, Ohman EM, Prosser C, Gibler WB, Langer A, Chang WC, Armstrong PW. Wong BY, et al. Am Heart J. 2002 Dec;144(6):987-94. doi: 10.1067/mhj.2002.126734. Am Heart J. 2002. PMID: 12486422 - Chlamydia pneumoniae antibody levels before coronary events in the Helsinki Heart Study as measured by different methods.
Paldanius M, Leinonen M, Virkkunen H, Tenkanen L, Sävykoski T, Mänttäri M, Saikku P. Paldanius M, et al. Diagn Microbiol Infect Dis. 2006 Nov;56(3):233-9. doi: 10.1016/j.diagmicrobio.2006.04.007. Epub 2006 Jun 6. Diagn Microbiol Infect Dis. 2006. PMID: 16757141 - Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.
Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Wong Y, Bernardes-Silva M, Ward M. Danesh J, et al. BMJ. 2000 Jul 22;321(7255):208-13. doi: 10.1136/bmj.321.7255.208. BMJ. 2000. PMID: 10903653 Free PMC article. - Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction.
Saikku P. Saikku P. Eur Heart J. 1993 Dec;14 Suppl K:62-5. Eur Heart J. 1993. PMID: 8131791 Review. - Epidemiologic association of Chlamydia pneumoniae and atherosclerosis: the initial serologic observation and more.
Saikku P. Saikku P. J Infect Dis. 2000 Jun;181 Suppl 3:S411-3. doi: 10.1086/315625. J Infect Dis. 2000. PMID: 10839725 Review.
Cited by
- Long term vascular complications of Coxiella burnetii infection in Switzerland: cohort study.
Lovey PY, Morabia A, Bleed D, Péter O, Dupuis G, Petite J. Lovey PY, et al. BMJ. 1999 Jul 31;319(7205):284-6. doi: 10.1136/bmj.319.7205.284. BMJ. 1999. PMID: 10426735 Free PMC article. - De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model.
Fong IW, Chiu B, Viira E, Jang D, Mahony JB. Fong IW, et al. Infect Immun. 1999 Nov;67(11):6048-55. doi: 10.1128/IAI.67.11.6048-6055.1999. Infect Immun. 1999. PMID: 10531266 Free PMC article. - Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens.
Apfalter P, Blasi F, Boman J, Gaydos CA, Kundi M, Maass M, Makristathis A, Meijer A, Nadrchal R, Persson K, Rotter ML, Tong CY, Stanek G, Hirschl AM. Apfalter P, et al. J Clin Microbiol. 2001 Feb;39(2):519-24. doi: 10.1128/JCM.39.2.519-524.2001. J Clin Microbiol. 2001. PMID: 11158100 Free PMC article. - Chronic infections and atherosclerosis/thrombosis.
Shah PK. Shah PK. Curr Atheroscler Rep. 2002 Mar;4(2):113-9. doi: 10.1007/s11883-002-0034-2. Curr Atheroscler Rep. 2002. PMID: 11822974 Review. - Immunology of non-trachomatis chlamydial infection.
Poussin M, Fuentes V, Orfila J. Poussin M, et al. Infect Dis Obstet Gynecol. 1996;4(3):122-7. doi: 10.1155/S1064744996000270. Infect Dis Obstet Gynecol. 1996. PMID: 18476081 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous